person · Reporting owner

MONAHAN MICHAEL P.

Disclosed activity across 3 companies

Tapewire entity: 24360
SEC CIK: 0001577151

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
SkinHealth Systems Inc.SKIN · Entity 6863	Chief Financial Officer	August 10, 2026	August 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SkinHealth Systems Inc.

Report date August 10, 2026 · Filed August 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	1,955,280	Reported balance After 2026-08-10 transaction · row 1 1 source row Row 1 · 2026-08-10 · Tax withholding · Disposed 32,357 · Balance 1,955,280 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Casper Sleep Inc.

Report date January 25, 2022 · Filed January 26, 2022

Section 16 reporting ended · disclosed 2022-01-26. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-01-25 transaction · row 1 1 source row Row 1 · 2022-01-25 · Disposition to issuer · Disposed 187,922 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.08 · Expires 2030-09-13	Direct	0	Reported balance After 2022-01-25 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-01-25 · Disposition to issuer · Disposed 234,000 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3: The options provided for vesting as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.

F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.

F3: The options provided for vesting as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024.

F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.

NUTRI SYSTEM INC /DE/

Report date March 08, 2019 · Filed March 11, 2019

Section 16 reporting ended · disclosed 2019-03-11. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-03-08 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2019-03-08 · Disposition to issuer · Disposed 110,625 · Balance 0 F1: This amount includes 10,202 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F2: This amount includes 21,368 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.
Common StockSEC Table I · non-derivative	Direct	6,259	Reported balance After 2019-03-08 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2019-03-08 · Grant · Acquired 6,259 · Balance 6,259 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value.
Common StockSEC Table I · non-derivative	Direct	20,202	Reported balance After 2019-03-08 transaction · row 3 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 3 · 2019-03-08 · Grant · Acquired 20,202 · Balance 20,202 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved.
Common StockSEC Table I · non-derivative	Direct	19,924	Reported balance After 2019-03-08 transaction · row 4 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 4 · 2019-03-08 · Grant · Acquired 19,924 · Balance 19,924 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved.
Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $20.94 · Expires 2023-01-04	Direct	0	Reported balance After 2019-03-08 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-08 · Disposition to issuer · Disposed 6,259 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value.
Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2019-03-08 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-08 · Disposition to issuer · Disposed 20,202 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.
Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2019-03-08 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-08 · Disposition to issuer · Disposed 19,924 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: This amount includes 10,202 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.

F2: This amount includes 21,368 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.

F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement);

F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.

F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder.

F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value.

F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder.

F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 10, 2026 Filed Aug 12, 2026 20:35 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	32,357	$0.64	$20,708.48	Disclosure SEC source: 0001628280-26-056277 · wk-form4_1786566949.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,955,280 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
April 09, 2026 Filed Apr 13, 2026 20:26 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	26,776	$0.92	$24,633.92	Disclosure SEC source: 0001628280-26-024900 · wk-form4_1776111961.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,987,637 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:05 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	746,681	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-020849 · wk-form4_1774386300.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,014,413 F1 · kind: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights. Read SEC document
March 17, 2026 Filed Mar 19, 2026 20:00 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	58,573	$1.17	$68,530.41	Disclosure SEC source: 0001628280-26-019782 · wk-form4_1773950421.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,267,732 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
August 10, 2025 Filed Aug 12, 2025 20:17 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	32,357	$1.89	$61,154.73	Disclosure SEC source: 0001628280-25-039897 · wk-form4_1755029843.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,326,305 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
June 01, 2025 Filed Jun 3, 2025 20:10 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	24,290	$1.63	$39,592.70	Disclosure SEC source: 0001628280-25-029044 · wk-form4_1748981394.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,358,662 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
April 09, 2025 Filed Apr 11, 2025 20:40 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	26,776	$1.08	$28,918.08	Disclosure SEC source: 0001628280-25-017546 · wk-form4_1744404014.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,382,952 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
March 17, 2025 Filed Mar 19, 2025 21:12 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	639,204	$1.32	$843,749.28	Disclosure SEC source: 0001628280-25-013881 · wk-form4_1742418728.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,409,728 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of March 17, 2025, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:07 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	24,227	$1.48	$35,855.96	Disclosure SEC source: 0001628280-24-049743 · wk-form4_1733260041.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770,524 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
August 10, 2024 Filed Aug 13, 2024 20:54 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	32,274	$1.12	$36,146.88	Disclosure SEC source: 0001628280-24-036963 · wk-form4_1723582456.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 794,751 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
April 09, 2024 Filed Apr 11, 2024 20:38 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	292,207	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-24-015844 · wk-form4_1712867911.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 827,025 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 9, 2024, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 9, 2024, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document
November 29, 2023 Filed Dec 1, 2023 21:14 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	176,711	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-23-040446 · wk-form4_1701465247.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,818 F1 · kind: Represents a retention award of restricted stock units (the "RSUs"). Fifty percent (50%) of the RSUs will vest on December 1, 2024, and the remaining fifty percent (50%) of the RSUs will vest on June 1, 2025, in each case subject to continued service through the applicable vesting date and certain acceleration rights. F1 · price: Represents a retention award of restricted stock units (the "RSUs"). Fifty percent (50%) of the RSUs will vest on December 1, 2024, and the remaining fifty percent (50%) of the RSUs will vest on June 1, 2025, in each case subject to continued service through the applicable vesting date and certain acceleration rights. Read SEC document
August 17, 2023 Filed Aug 18, 2023 16:38 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	PurchaseClass A Common Stock	5,000	$6.02	$30,123.00	Disclosure SEC source: 0001628280-23-029946 · wk-form4_1692376701.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,107 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.02 to $6.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document
August 10, 2023 Filed Aug 11, 2023 22:50 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	353,107	Not disclosed	Not disclosed	Disclosure SEC source: 0001577151-23-000008 · wk-form4_1691794221.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,107 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of August 10, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of August 10, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document
January 25, 2022 Filed Jan 26, 2022 22:03 UTC	Casper Sleep Inc. CSPR · Entity 131068	Disposition to issuerStock Option · Derivative	234,000	$0.00 Strike: $8.08	$0.00	Disclosure SEC source: 0001598674-22-000037 · wf-form4_164323457507539.xml · derivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234,000 shares Expires 2030-09-13 F4 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3 · derivative.exercise_date: The options provided for vesting as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024. Read SEC document
January 25, 2022 Filed Jan 26, 2022 22:03 UTC	Casper Sleep Inc. CSPR · Entity 131068	Disposition to issuerCommon Stock	187,922	$6.90	$1,296,661.80	Disclosure SEC source: 0001598674-22-000037 · wf-form4_164323457507539.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F2 · price: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. Read SEC document
September 14, 2021 Filed Sep 15, 2021 20:29 UTC	Casper Sleep Inc. CSPR · Entity 131068	SaleCommon Stock	10,956	$5.20	$56,971.20	Disclosure SEC source: 0001598674-21-000080 · wf-form4_163173778120682.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,922 F1 · shares: Represents shares sold pursuant to a sell-to-cover election to satisfy tax withholding obligations in connection with the vesting of 29,250 restricted stock units on September 13, 2021. Read SEC document
March 05, 2021 Filed Mar 10, 2021 00:30 UTC	Casper Sleep Inc. CSPR · Entity 131068	GrantCommon Stock	81,878	$0.00	$0.00	Disclosure SEC source: 0001598674-21-000028 · wf-form4_161533617133814.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,878 F1 · shares: The Reporting Person received an award of 81,878 restricted stock units on March 5, 2021. The restricted stock units vest as to (i) 25% on March 5, 2022; (ii) 25% on March 5, 2023; (iii) 25% on March 5, 2024 and (iv) 25% on March 5, 2025. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document
September 13, 2020 Filed Sep 15, 2020 20:07 UTC	Casper Sleep Inc. CSPR · Entity 131068	GrantStock Option · Derivative	234,000	$8.08 Strike: $8.08	$1,890,720.00	Disclosure SEC source: 0001598674-20-000051 · wf-form4_160020044715922.xml · derivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,000 Underlying: Common Stock · 234,000 shares Expires 2030-09-13 F2 · derivative.underlying_shares: The Reporting Person received an award of 234,000 non-qualified stock options on September 13, 2020. The option award vest as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024. Each option represents a right to receive one share of Issuer common stock upon exercise Read SEC document
September 13, 2020 Filed Sep 15, 2020 20:07 UTC	Casper Sleep Inc. CSPR · Entity 131068	GrantCommon Stock	117,000	$0.00	$0.00	Disclosure SEC source: 0001598674-20-000051 · wf-form4_160020044715922.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000 F1 · shares: The Reporting Person received an award of 117,000 restricted stock units on September 13, 2020. The restricted stock units vest as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Disposition to issuerPerformance-Based Restricted Stock Units · Derivative	19,924	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · derivative · entry 7 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,924 shares Expires not disclosed F8 · derivative.exercise_price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7 · kind: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F3 · derivative.exercise_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.exercise_date: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. F3 · derivative.expiration_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.expiration_date: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Disposition to issuerPerformance-Based Restricted Stock Units · Derivative	20,202	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · derivative · entry 6 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,202 shares Expires not disclosed F8 · derivative.exercise_price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7 · kind: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F3 · derivative.exercise_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.exercise_date: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. F3 · derivative.expiration_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.expiration_date: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Disposition to issuerOption to Purchase Common Stock · Derivative	6,259	Not disclosed Strike: $20.94	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · derivative · entry 5 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,259 shares Expires 2023-01-04 F5 · kind: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	GrantCommon Stock	19,924	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · nonDerivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 F7 · price: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	GrantCommon Stock	20,202	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,202 F7 · price: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	GrantCommon Stock	6,259	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,259 F5 · price: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document
March 08, 2019 Filed Mar 11, 2019 14:56 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Disposition to issuerCommon Stock	110,625	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-018374 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: This amount includes 10,202 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F2 · shares: This amount includes 21,368 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F3 · price: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · price: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. Read SEC document
February 14, 2019 Filed Feb 19, 2019 08:03 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	GrantCommon stock	21,368	$0.00	$0.00	Disclosure SEC source: 0001209191-19-010871 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,240 F1 · security: Restricted stock units were granted upon the achievement of certain specified performance goals and will vest, subject to continued employment, on December 31, 2019. Read SEC document
January 04, 2019 Filed Jan 7, 2019 16:04 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	510	$43.98	$22,429.80	Disclosure SEC source: 0001209191-19-002487 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,872 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
January 03, 2019 Filed Jan 7, 2019 16:04 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	1,006	$43.45	$43,710.70	Disclosure SEC source: 0001209191-19-002487 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,382 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
January 02, 2019 Filed Jan 3, 2019 16:03 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	1,082	$43.48	$47,045.36	Disclosure SEC source: 0001209191-19-000863 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,388 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
December 31, 2018 Filed Jan 3, 2019 16:03 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	9,344	$43.88	$410,014.72	Disclosure SEC source: 0001209191-19-000863 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,470 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock options, .001 (right to buy) · Derivative	2,301	$0.00 Strike: $20.94	$0.00	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · derivative · entry 7 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,259 Underlying: Common Shares · 2,301 shares Expires 2023-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock options, .001 (right to buy) · Derivative	5,554	$0.00 Strike: $14.95	$0.00	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · derivative · entry 6 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,560 Underlying: Common Shares · 5,554 shares Expires 2021-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	SaleCommon stock	12,145	$40.05	$486,440.04	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · nonDerivative · entry 5 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,814 F1 · kind: Sale pursuant to a 10(b)5-1 plan. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	SaleCommon stock	2,301	$40.00	$92,040.00	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · nonDerivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,959 F1 · kind: Sale pursuant to a 10(b)5-1 plan. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock	2,301	$20.94	$48,182.94	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	SaleCommon stock	5,554	$40.00	$222,160.00	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,959 F1 · kind: Sale pursuant to a 10(b)5-1 plan. Read SEC document
July 06, 2018 Filed Jul 6, 2018 16:11 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock	5,554	$14.95	$83,032.30	Disclosure SEC source: 0001209191-18-041864 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 20, 2018 Filed Mar 22, 2018 16:05 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	627	$29.55	$18,527.85	Disclosure SEC source: 0001209191-18-021240 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,959 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:29 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	GrantCommon stock	21,490	$0.00	$0.00	Disclosure SEC source: 0001209191-18-012428 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,586 F1 · security: Restricted stock units were granted upon the achievement of certain specified performance goals and will vest, subject to continued employment, on December 31, 2018. Read SEC document
January 05, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock options, .001 (right to buy) · Derivative	3,958	$0.00 Strike: $20.94	$0.00	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · derivative · entry 8 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,114 Underlying: Common Shares · 3,958 shares Expires 2023-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 05, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock options, .001 (right to buy) · Derivative	6,042	$0.00 Strike: $18.98	$0.00	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · derivative · entry 7 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,072 Underlying: Common Shares · 6,042 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 05, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	SaleCommon stock	3,958	$49.60	$196,316.80	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · nonDerivative · entry 6 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,096 F2 · kind: Sale pursuant to a 10(b)5-1 plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $50.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
January 05, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	SaleCommon stock	6,042	$49.60	$299,683.20	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · nonDerivative · entry 5 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,054 F2 · kind: Sale pursuant to a 10(b)5-1 plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $50.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
January 05, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock	3,958	$20.94	$82,880.52	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · nonDerivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 05, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Exercise / conversionCommon stock	6,042	$18.98	$114,677.16	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 04, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	564	$50.40	$28,425.60	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,096 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
January 03, 2018 Filed Jan 5, 2018 17:23 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	Tax withholdingCommon stock	1,143	$52.05	$59,493.15	Disclosure SEC source: 0001209191-18-002510 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,660 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document
January 02, 2018 Filed Jan 3, 2018 17:18 UTC	NUTRI SYSTEM INC /DE/ NTRI · Entity 159276	GrantCommon stock	9,962	$0.00	$0.00	Disclosure SEC source: 0001209191-18-001133 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,803 F2 · shares: Restricted shares were granted on January 2, 2018. Shares vest over three years in equal installments on January 2nd of each year. Price per share on day of grant is $52.70. F2 · price: Restricted shares were granted on January 2, 2018. Shares vest over three years in equal installments on January 2nd of each year. Price per share on day of grant is $52.70. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.